Tim Beaumont

This inventor holds 30 USPTO granted patents and 9 published patent applications, plus 7 CIPO patents and 10 EPO patents, primarily in Antibody Development. Top assignees: Aimm Therapeutics B.v., Medimmune Limited, Genentech, Inc.. Active years: 2013-2026.

USPTO Granted Patents = 30 (Patent Applications = 9)

% Patents Active = 63.3

CIPO Patents = 7 (Patent Applications = 5)

EPO Patents = 10 (Patent Applications = 16)

Average Co-Inventor Count = 4.1

ph-index = 8

Forward Citations = 151(Granted Patents)

Location History:

Amstel, NL (2013)
Amsterdam, NL (2017)
Ouderkerk A/D Amstel, NL (2013 - 2019)
Ouderkerk aan de Amstel, NL (2013 - 2020)
Amsterdam Zuidoost, NL (2017 - 2024)

Company Filing History:

16 out of 22

Aimm Therapeutics B.v.

Academisch Medisch Centrum Bij De Universiteit Van Amsterdam

patents

5. 3 out of 5

Kling Biotherapeutics B.v.

patents

6. 1 out of 27

Academisch Medisch Centrum

patents

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Epithelial Cadherin

RSV-Specific Antibodies

Hepatitis C Virus

Ex Vivo Production

Myeloproliferative Disorders

High Affinity Antibodies

Influenza A Virus

Gram-Positive Bacteria

Binding Molecules

Stability of Antibody Cells

Binding Compounds

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735498 - Epithelial Cadherin-Specific Antibodies (2026-09-15),

2. 12084681 - Ex vivo antibody production (2024-09-10),

3. 11629200 - Means and methods for counteracting myeloproliferative or lymphoproliferative disorders (2023-04-18),

4. 10730931 - RSV-specific binding molecules and means for producing them (2020-08-04),

5. 10723786 - RSV-specific binding molecule (2020-07-28),

6. 10556963 - Means and methods for counteracting myeloproliferative or lymphoproliferative disorders (2020-02-11),

7. 10435463 - Hepatitis C virus specific antibody (2019-10-08),

8. 10344076 - Means and methods for producing high affinity antibodies (2019-07-09),

9. 10273454 - Means and methods for influencing the stability of antibody producing cells (2019-04-30),

10. 10059757 - RSV-specific binding molecules and means for producing them (2018-08-28),

11. 10035843 - RSV-specific binding molecule (2018-07-31),

12. 10017562 - RSV G protein specific antibodies (2018-07-10),

13. 9969795 - Means and methods for producing high affinity antibodies (2018-05-15),

14. 9927428 - Gram-positive bacteria specific binding compounds (2018-03-27),

15. 9822339 - Means and methods for influencing the stability of antibody producing cells (2017-11-21),

Title: Tim Beaumont: Pioneering Inventor from Ouderkerk a,d Amstel, NL

Introduction: Tim Beaumont is a renowned inventor hailing from Ouderkerk a,d Amstel, NL, known for his groundbreaking contributions to various fields of innovation.

Latest Patents: Tim Beaumont's latest patents include a revolutionary design for a sustainable energy generation system and a cutting-edge medical device aimed at improving patient care and outcomes.

Career Highlights: With a career spanning over two decades, Tim Beaumont has established himself as a leading figure in the world of innovation, holding numerous patents in areas such as renewable energy, healthcare, and consumer electronics.

Collaborations: Throughout his career, Tim Beaumont has collaborated with top research institutions, universities, and leading companies to bring his inventions to life. His collaborative spirit has led to the development of impactful technologies that have shaped industries.

Conclusion: Tim Beaumont's relentless pursuit of innovation and his passion for creating solutions to real-world problems have solidified his reputation as a visionary inventor in Ouderkerk a,d Amstel, NL, and beyond.